• Article

A Network Meta-Analysis of Randomized, Controlled Trials of Ustekinumab and Adalimumab for Moderate-To-Severe Psoriasis

Citation

Odom, D., Brogan, A., Talbird, S., & Schenkel, B. (2013). A Network Meta-Analysis of Randomized, Controlled Trials of Ustekinumab and Adalimumab for Moderate-To-Severe Psoriasis. Value in Health, 16(3), A112-A112.